Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Utilization of remimazolam during cesarean section for a parturient with prior birth trauma.

Created on 12 Nov 2026

Authors

James Parry, Courtney Hood

Published in

Proceedings (Baylor University. Medical Center). Pages 1-3. Nov 11, 2026. Epub Nov 11, 2026.

Abstract

The placement of neuraxial anesthesia, and cesarean section itself, can be a source of significant anxiety and discomfort. While anxiolysis may improve patient comfort, the use of benzodiazepines is often limited by concerns about maternal respiratory depression, neonatal sedation, and hypotonia. Remimazolam (ByFavo™ in the US) is a novel, ultra-short-acting benzodiazepine characterized by a rapid onset, predictable recovery, and favorable hemodynamic profile. As a category of medications, benzodiazepines do cross the placenta and may cause respiratory depression, hypotension, and sedation in neonates. However, the novel structure and rapid metabolism of remimazolam is responsible for its clinically decreased recovery time and makes it an ideal agent for procedural anxiolysis for obstetric procedures. Remimazolam was approved for procedural sedation in the US in 2020 for adult populations; however, its use in obstetric anesthesia remains off-label and largely underutilized due to limited safety data. Despite this, it has been described in case reports and explored for potential benefits such as the prevention of nausea and vomiting during cesarean delivery. This case illustrates a novel application of remimazolam in a sensitive population, highlighting its potential as a safe and effective agent for anxiolysis in the obstetric setting.

PMID:
43013692
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement